Form 4: Broadridge Director Duelks Exercises Options and Sells Shares

Sentiment:

SEC Form 4 Filing


Director Robert N. Duelks exercised stock options and sold shares of Broadridge Financial Solutions, Inc. on June 5, 2024.

Summary

  • On June 5, 2024, Robert N. Duelks, a director of Broadridge Financial Solutions, Inc., exercised stock options to acquire 6,469 shares of common stock at a price of $45.09 per share.
  • Following the exercise of options, Duelks sold 3,473 shares of common stock at a weighted average price of $198.0582 per share, with individual sales prices ranging from $198.01 to $198.15.
  • After these transactions, Duelks directly owns 22,588 shares of Broadridge common stock.
  • Duelks also indirectly owns 5,445 shares through BOMAR II LLC, 17,000 shares through the Mary E. Duelks 2007 Revocable Trust, and 131 shares through the Robert N. Duelks 2007 Revocable Trust.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.

Industry Context

Executive stock transactions are common and closely watched as they can provide insights into management's perspective on the company's valuation and future prospects. This transaction is a routine disclosure.

Comparison to Industry Standards

  • Executive compensation packages often include stock options to align management's interests with those of shareholders.
  • The exercise of options and subsequent sale of shares is a typical wealth diversification strategy for executives.
  • The reported transaction is consistent with standard practices for executive stock ownership and trading.

Stakeholder Impact

  • The transaction may have a minor impact on shareholders as it involves the sale of shares by a director.
  • The impact on employees, customers, suppliers, and creditors is likely negligible.

Key Dates

DateDescription
11/13/2014Original grant date of the stock options exercised.
06/05/2024Date of the stock option exercise and share sale.
06/06/2024Date of signature for the Form 4 filing.
11/13/2024Expiration date of the stock options exercised.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.